Evidence map›Paper›PMID 26419769›Full record

ArticleJournal of the American Society for Mass Spectrometry2015

reSpect: software for identification of high and low abundance ion species in chimeric tandem mass spectra.

David Shteynberg, Luis Mendoza, Michael R Hoopmann, Zhi Sun, Frank Schmidt, Eric W Deutsch, Robert L Moritz

Abstract read
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. AData in brief · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Microbial Metabolites Annotation by Mass Spectrometry-Based Metabolomics.Advances in experimental medicine and biology · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The PeptideAtlas of the Domestic Laying Hen.Journal of proteome research · 2017
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David ShteynbergInstitute for Systems Biology, Seattle, WA, USA.
Luis MendozaInstitute for Systems Biology, Seattle, WA, USA.
Michael R HoopmannInstitute for Systems Biology, Seattle, WA, USA.
Zhi SunInstitute for Systems Biology, Seattle, WA, USA.
Frank SchmidtZIK-FunGene Junior Research Group Applied Proteomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.
Eric W DeutschInstitute for Systems Biology, Seattle, WA, USA. edeutsch@systemsbiology.org.
Robert L MoritzInstitute for Systems Biology, Seattle, WA, USA.

Funding

Quantitative Systems BiologyP50GM076547 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI BALIGA, NITIN S · 2006 to 2016
$30.6M
Shortening the development cycle time of Trans Proteomic Pipeline tools with high performance computingR01GM087221 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI DEUTSCH, ERIC, MORITZ, ROBERT L · 2010 to 2021
$6.0M
FAIMS-Selected Reaction Monitoring to Quantitative Protein Networks in DiseaseS10RR027584 · NCRR · INSTITUTE FOR SYSTEMS BIOLOGY · PI MORITZ, ROBERT L · 2011 to 2011
$576k
NCRR NIH HHS S10 RR027584NCRR NIH HHS S10RR027584NIGMS NIH HHS 2P50 GM076547NIGMS NIH HHS P50 GM076547NIGMS NIH HHS R01 GM087221NIGMS NIH HHS R01GM087221
6 · The paper itself

Abstract

Most shotgun proteomics data analysis workflows are based on the assumption that each fragment ion spectrum is explained by a single species of peptide ion isolated by the mass spectrometer; however, in reality mass spectrometers often isolate more than one peptide ion within the window of isolation that contribute to additional peptide fragment peaks in many spectra. We present a new tool called reSpect, implemented in the Trans-Proteomic Pipeline (TPP), which enables an iterative workflow whereby fragment ion peaks explained by a peptide ion identified in one round of sequence searching or spectral library search are attenuated based on the confidence of the identification, and then the altered spectrum is subjected to further rounds of searching. The reSpect tool is not implemented as a search engine, but rather as a post-search engine processing step where only fragment ion intensities are altered. This enables the application of any search engine combination in the iterations that follow. Thus, reSpect is compatible with all other protein sequence database search engines as well as peptide spectral library search engines that are supported by the TPP. We show that while some datasets are highly amenable to chimeric spectrum identification and lead to additional peptide identification boosts of over 30% with as many as four different peptide ions identified per spectrum, datasets with narrow precursor ion selection only benefit from such processing at the level of a few percent. We demonstrate a technique that facilitates the determination of the degree to which a dataset would benefit from chimeric spectrum analysis. The reSpect tool is free and open source, provided within the TPP and available at the TPP website. Graphical Abstract ᅟ.

Indexed as

SoftwareIonsPeptide MappingProteomicsTandem Mass SpectrometryIonsBioinformaticsChimeric spectraProteomicsShotgun proteomics

Identifiers

PMID26419769
PMCPMC4750398

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.